XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Cash flows from operating activities    
Net income $ 547.6 $ 578.3
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 149.9 162.5
Equity compensation expense 29.6 26.7
Deferred income taxes 33.1 3.6
Impairment of long-lived assets 18.9 5.4
Tax benefit on exercise of share options (0.2) (6.4)
Foreign currency (gains) losses (14.7) 2.2
Other non-cash charges 5.1 5.3
Change in assets and liabilities:    
Receivables, net 17.1 73.6
Inventories 20.8 (20.2)
Prepaid expenses and other current assets 31.9 (39.2)
Accounts payable (21.4) 74.4
Accrued expenses and other current liabilities 54.6 11.8
Other 1.0 17.7
Net cash provided by operating activities 873.3 895.7
Cash flows from investing activities    
Capital expenditures (83.8) (147.7)
Purchase of intangible assets (3.2) (5.6)
Cash paid for business acquisitions, net of cash acquired (1,414.5) (480.6)
Realized gain on hedge related to Jimmy Choo acquisition 4.7 0.0
Net cash used in investing activities (1,496.8) (633.9)
Cash flows from financing activities    
Debt borrowings 2,078.8 361.8
Debt repayments (1,222.1) (199.6)
Repurchases of treasury shares (161.0) (754.8)
Exercises of employee share options 5.5 8.0
Other financing activities (0.2) 0.0
Net cash used in financing activities 701.0 (584.6)
Effect of exchange rate changes on cash and cash equivalents 10.3 (9.3)
Net increase (decrease) in cash and cash equivalents and restricted cash 87.8 (332.1)
Beginning of period (including restricted cash of $1.9 million at April 1, 2017) 229.6 702.0
End of period (including restricted cash of $0.3 million at December 30, 2017 and $1.1 million at December 31, 2016) 317.4 369.9
Supplemental disclosures of cash flow information    
Cash paid for interest 6.5 3.1
Cash paid for income taxes 85.0 164.7
Supplemental disclosure of non-cash investing and financing activities    
Accrued capital expenditures $ 22.0 $ 36.2